fbpx

Elixinol Stock vs. Charlotte’s Web Stock

March 16. 2019. 6 mins read

This year we’ve taken a small break from looking at marijuana stocks and trained our focus on the recent legalization of hemp in the United States and the popularity of cannabidiol or CBD products for applications like reducing anxiety or facilitating sleep. We talked about how hemp food relates to CBD, and pointed out A Good CBD Stock for Cannabidiol Investors. Now, we want to look at another cannabidiol stock that’s come across our radar – Elixinol – that seems to be quite similar to Charlotte’s Web. We decided to take a closer look as to how Elixinol stock compares to Charlotte’s Web stock. (All numbers are in USD unless stated otherwise.)

About Elixinol Stock

Founded in 2014, Elixinol Global (EXL:AU) is a publicly traded Australian firm that manufactures and distributes hemp-based dietary supplements and skincare products through a number of subsidiaries. In January of 2018, shares of Elixinol began trading on the Australian Stock eXchange (ASX) and have since risen +105% giving the company a present-day market cap of around $291 million. The company can be subdivided into three separate entities that include a hemp food business based out of Australia, a CBD supplements business based out of Colorado, and an Australian entity that plans t

Become a premium member and get access to hundreds of premium articles, reports and additional content.

Nanalyze Premium is your comprehensive guide to investing in disruptive technologies. Read by the top investment banks, management consultancies, VCs, and research houses. Trusted by over 100,000 institutional and retail investors. Covering disruptive technologies for over 18 years.